Compounds > bromocriptine
Page last updated: 2024-08-23

bromocriptine and Ovarian Hyperstimulation Syndrome, Familial Gestational Spontaneous

bromocriptine has been researched along with Ovarian Hyperstimulation Syndrome, Familial Gestational Spontaneous in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (10.00)29.6817
2010's7 (70.00)24.3611
2020's2 (20.00)2.80

Authors

AuthorsStudies
Bu, X; Jia, C; Liu, Y; Ma, Y; Wang, S; Zhang, Q1
Hart, RJ; Mourad, SM; Tang, H; Wang, A; Zhai, SD1
Čehić, E; Franulić, D; Grgić, F; Kasum, M; Lila, A; Orešković, S; Vujić, G1
Beketić-Orešković, L; Ježek, D; Kasum, M; Orešković, S; Pekez, M; Stanić, P; Vrčić, H1
Hart, RJ; Mourad, S; Tang, H; Zhai, SD1
Haidbauer, R; Murtinger, M; Spitzer, D; Wogatzky, J; Zech, MH; Zech, NH1
Wiwanitkit, V2
Baracat, EC; Beltrame, AL; Motta, EL; Serafini, P; Soares Júnior, JM1
Ando, H; Fukugaki, H; Matsuzawa, K; Mizutani, S; Murata, Y; Nagasaka, T; Saito, K; Takahashi, I1

Reviews

4 review(s) available for bromocriptine and Ovarian Hyperstimulation Syndrome, Familial Gestational Spontaneous

ArticleYear
Dopamine agonists for preventing ovarian hyperstimulation syndrome.
    The Cochrane database of systematic reviews, 2021, 04-14, Volume: 4

    Topics: Abortion, Spontaneous; Administration, Oral; Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Fertilization in Vitro; Humans; Live Birth; Ovarian Hyperstimulation Syndrome; Placebos; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Sperm Injections, Intracytoplasmic

2021
Current Medical Strategies in the Prevention of Ovarian Hyperstimulation Syndrome
    Acta clinica Croatica, 2017, Volume: 56, Issue:1

    Topics: Aminoquinolines; Bromocriptine; Buserelin; Cabergoline; Chorionic Gonadotropin; Dopamine Agonists; Ergolines; Estradiol; Estrogens; Female; Fertility Agents, Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Oocyte Retrieval; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Pregnancy Rate; Progesterone; Progestins; Triptorelin Pamoate

2017
Dopamine agonists in prevention of ovarian hyperstimulation syndrome.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2014, Volume: 30, Issue:12

    Topics: Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction

2014
Dopamine agonists for preventing ovarian hyperstimulation syndrome.
    The Cochrane database of systematic reviews, 2016, 11-30, Volume: 11

    Topics: Abortion, Spontaneous; Administration, Oral; Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Ovarian Hyperstimulation Syndrome; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Reproductive Techniques, Assisted

2016

Trials

1 trial(s) available for bromocriptine and Ovarian Hyperstimulation Syndrome, Familial Gestational Spontaneous

ArticleYear
The effects of bromocriptine on VEGF, kidney function and ovarian hyperstimulation syndrome in in vitro fertilization patients: a pilot study.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2013, Volume: 29, Issue:3

    Topics: Adult; Brazil; Bromocriptine; Dopamine Agonists; Double-Blind Method; Female; Fertilization in Vitro; Glomerular Filtration Rate; Humans; Incidence; Infertility, Female; Kidney; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Patient Dropouts; Pilot Projects; Risk; Severity of Illness Index; Sodium; Vascular Endothelial Growth Factor A

2013

Other Studies

5 other study(ies) available for bromocriptine and Ovarian Hyperstimulation Syndrome, Familial Gestational Spontaneous

ArticleYear
Comparison of bromocriptine and hydroxyethyl starch in the prevention of ovarian hyperstimulation syndrome.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2022, Volume: 159, Issue:3

    Topics: Bromocriptine; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Retrospective Studies; Starch

2022
Dopamine agonist bromocriptine for the prevention of ovarian hyperstimulation syndrome.
    Fertility and sterility, 2011, Jun-30, Volume: 95, Issue:8

    Topics: Adult; Austria; Bromocriptine; Dopamine Agonists; Female; Fertilization in Vitro; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Pregnancy Rate; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Young Adult

2011
Prevention of ovarian hyperstimulation syndrome.
    Fertility and sterility, 2011, Jun-30, Volume: 95, Issue:8

    Topics: Bromocriptine; Dopamine Agonists; Female; Fertilization in Vitro; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Pregnancy Rate; Risk Factors; Severity of Illness Index; Treatment Outcome

2011
Ovarian hyperstimulation syndrome.
    Singapore medical journal, 2011, Volume: 52, Issue:5

    Topics: Adult; Bromocriptine; Female; Gonadotropins; Humans; Ovarian Hyperstimulation Syndrome; Pregnancy; Research Design; Retrospective Studies

2011
Successful pregnancy after bromocriptine therapy in an anovulatory woman complicated with ovarian hyperstimulation caused by follicle-stimulating hormone-producing plurihormonal pituitary microadenoma.
    The Journal of clinical endocrinology and metabolism, 2003, Volume: 88, Issue:5

    Topics: Adenoma; Adult; Anovulation; Bromocriptine; Estradiol; Female; Follicle Stimulating Hormone; Follicle Stimulating Hormone, beta Subunit; Humans; Infertility, Female; Magnetic Resonance Imaging; Ovarian Hyperstimulation Syndrome; Pituitary Neoplasms; Pregnancy; Prolactin; Receptors, Dopamine D2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tomography, X-Ray Computed

2003